University of Colorado Anschutz Medical Campus-Led Team Receives Up to $46 Million to Develop Innovative Treatment to Cure Blindness
| | | | | | |

University of Colorado Anschutz Medical Campus-Led Team Receives Up to $46 Million to Develop Innovative Treatment to Cure Blindness

On Dec. 2, 2024, the University of Colorado Anschutz Medical Campus announced it will receive up to $46…

FDA Approves Genentech’s Itovebi, a Targeted Treatment for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
| | | | |

FDA Approves Genentech’s Itovebi, a Targeted Treatment for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation

On Oct. 10, 2024, Genentech announced today that the U.S. Food and Drug Administration (FDA) approved ItovebiTM (inavolisib),…

FDA Approves Ocrevus Zunovo™ as the First and Only Twice-A-Year 10-Minute Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis
| | |

FDA Approves Ocrevus Zunovo™ as the First and Only Twice-A-Year 10-Minute Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis

On Sept. 13, 2024, Genentech announced  that the U.S. Food and Drug Administration (FDA) had approved Ocrevus Zunovo™…

Biden announced $150 million in research grants as part of his ‘moonshot’ push to fight cancer
| | | | | | | | | |

Biden announced $150 million in research grants as part of his ‘moonshot’ push to fight cancer

On Aug. 13, 2024, President Joe Biden announced $150 million in awards from the Advanced Research Projects Agency…